{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T01:42:34Z","timestamp":1783820554323,"version":"3.55.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006108","name":"U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR002548"],"award-info":[{"award-number":["UL1TR002548"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["P30EY025585(BA-A)"],"award-info":[{"award-number":["P30EY025585(BA-A)"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background\/Objective<\/jats:title>\n            <jats:p>To provide a large-scale analysis on the demographics and ocular comorbidities in Ehlers-Danlos Syndrome (EDS) patients in the US.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Subjects\/Methods<\/jats:title>\n            <jats:p>This is an exploratory cross-sectional study comparing medical records of EDS patients to the general population on demographic variables and ICD-10 ocular diagnoses. A research platform with de-identified EHR data of over 99 million patients across 60 healthcare organizations was utilized. Groups were stratified by 30-year age groups. Patients aged 0\u201361+ with an ICD-10 diagnosis of EDS (76,526), the general platform population aged 0\u201361+ (99,836,639), and patients with a concurrent ICD-10 ocular diagnosis were queried to determine the prevalence of EDS across demographic variables, ocular disease, and odds of ocular disease. Statistical analysis was conducted using Microsoft Excel and R studio, using <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01 and 95% confidence intervals (CI).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>An EDS diagnosis was most prevalent in white females aged 0\u201330 years old (259.6 per 100,000). The majority of ocular diagnoses were more prevalent in the 0\u201360-year-old EDS population compared to the general population including myopia (5227.0 per 100,000) and dry eye (4211.6 per 100,000). Overall, diagnoses of angioid streaks (POR 18.72, 95% CI 10.32, 33.94) and idiopathic intracranial hypertension (IIH) (POR 18.43, 95% CI 17.51, 19.39) showed the highest increased odds in patients with EDS while significantly decreased odds were shown for type 2 diabetic retinopathy, age-related macular degeneration, and retinal vein occlusion.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>EDS was associated with increased odds of having a concurrent ocular pathology, suggesting that, upon diagnosis of EDS, referral to ophthalmology may be valuable.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1038\/s41433-025-03787-1","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T16:07:46Z","timestamp":1744301266000},"page":"1990-1997","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Ocular manifestations in Ehlers-Danlos syndrome"],"prefix":"10.1038","volume":"39","author":[{"given":"Sonia B.","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7873-669X","authenticated-orcid":false,"given":"Jacqueline K.","family":"Shaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Kaelber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishi P.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0458-4181","authenticated-orcid":false,"given":"Katherine E.","family":"Talcott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,10]]},"reference":[{"key":"3787_CR1","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1097\/ICU.0000000000001002","volume":"34","author":"SS Rachapudi","year":"2023","unstructured":"Rachapudi SS, Laylani NA, Davila-Siliezar PA, Lee AG. Neuro-ophthalmic manifestations of Ehlers\u2013Danlos syndrome. Curr Opin Ophthalmol. 2023;34:476\u201380. https:\/\/doi.org\/10.1097\/ICU.0000000000001002.","journal-title":"Curr Opin Ophthalmol"},{"key":"3787_CR2","unstructured":"Miklovic T, Sieg VC Ehlers-Danlos Syndrome. In: StatPearls. StatPearls Publishing; 2024. Accessed April 6, 2024. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK549814\/"},{"key":"3787_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-020-0194-9","volume":"6","author":"F Malfait","year":"2020","unstructured":"Malfait F, Castori M, Francomano CA, Giunta C, Kosho T, Byers PH. The Ehlers\u2013Danlos syndromes. Nat Rev Dis Prim. 2020;6:1\u201325. https:\/\/doi.org\/10.1038\/s41572-020-0194-9.","journal-title":"Nat Rev Dis Prim"},{"key":"3787_CR4","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.ajhg.2018.02.018","volume":"102","author":"PR Blackburn","year":"2018","unstructured":"Blackburn PR, Xu Z, Tumelty KE, Zhao RW, Monis WJ, Harris KG, et al. Bi-allelic Alterations in AEBP1 Lead to Defective Collagen Assembly and Connective Tissue Structure Resulting in a Variant of Ehlers-Danlos Syndrome. Am J Hum Genet. 2018;102:696\u2013705. https:\/\/doi.org\/10.1016\/j.ajhg.2018.02.018.","journal-title":"Am J Hum Genet"},{"key":"3787_CR5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/ajmg.c.31552","volume":"175","author":"F Malfait","year":"2017","unstructured":"Malfait F, Francomano C, Byers P, Belmont J, Berglund B, Black J, et al. The 2017 international classification of the Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet. 2017;175:8\u201326. https:\/\/doi.org\/10.1002\/ajmg.c.31552.","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"3787_CR6","doi-asserted-by":"publisher","first-page":"547","DOI":"10.3390\/genes11050547","volume":"11","author":"M Ritelli","year":"2020","unstructured":"Ritelli M, Colombi M. Molecular Genetics and Pathogenesis of Ehlers\u2013Danlos Syndrome and Related Connective Tissue Disorders. Genes. 2020;11:547 https:\/\/doi.org\/10.3390\/genes11050547.","journal-title":"Genes"},{"key":"3787_CR7","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/ajmg.c.31550","volume":"175","author":"AF Brady","year":"2017","unstructured":"Brady AF, Demirdas S, Fournel-Gigleux S, Ghali N, Giunta C, Kapferer-Seebacher I, et al. The Ehlers-Danlos syndromes, rare types. Am J Med Genet C Semin Med Genet. 2017;175:70\u2013115. https:\/\/doi.org\/10.1002\/ajmg.c.31550.","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"3787_CR8","first-page":"229","volume":"12","author":"HN Yeowell","year":"1993","unstructured":"Yeowell HN, Pinnell SR. The Ehlers-Danlos syndromes. Semin Dermatol. 1993;12:229\u201340.","journal-title":"Semin Dermatol"},{"key":"3787_CR9","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/BF00201664","volume":"93","author":"I Hausser","year":"1994","unstructured":"Hausser I, Anton-Lamprecht I. Differential ultrastructural aberrations of collagen fibrils in Ehlers-Danlos syndrome types I-IV as a means of diagnostics and classification. Hum Genet. 1994;93:394\u2013407. https:\/\/doi.org\/10.1007\/BF00201664.","journal-title":"Hum Genet"},{"key":"3787_CR10","doi-asserted-by":"publisher","first-page":"337","DOI":"10.17796\/jcpd.30.4.72426m58695tg2h0","volume":"30","author":"OM Yassin","year":"2006","unstructured":"Yassin OM, Rihani FB. Multiple developmental dental anomalies and hypermobility type Ehlers-Danlos syndrome. J Clin Pediatr Dent. 2006;30:337\u201341. https:\/\/doi.org\/10.17796\/jcpd.30.4.72426m58695tg2h0.","journal-title":"J Clin Pediatr Dent"},{"key":"3787_CR11","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1111\/jgh.15927","volume":"37","author":"PA Thwaites","year":"2022","unstructured":"Thwaites PA, Gibson PR, Burgell RE. Hypermobile Ehlers-Danlos syndrome and disorders of the gastrointestinal tract: What the gastroenterologist needs to know. J Gastroenterol Hepatol. 2022;37:1693\u2013709. https:\/\/doi.org\/10.1111\/jgh.15927.","journal-title":"J Gastroenterol Hepatol"},{"key":"3787_CR12","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/cge.14245","volume":"103","author":"M Shabani","year":"2023","unstructured":"Shabani M, Abdollahi A, Brar BK, MacCarrick GL, Ambale Venkatesh B, Lima J, et al. Vascular aneurysms in Ehlers-Danlos syndrome subtypes: A systematic review. Clin Genet. 2023;103:261\u20137. https:\/\/doi.org\/10.1111\/cge.14245.","journal-title":"Clin Genet"},{"key":"3787_CR13","doi-asserted-by":"publisher","first-page":"582","DOI":"10.21037\/acs.2017.11.03","volume":"6","author":"JAN Meester","year":"2017","unstructured":"Meester JAN, Verstraeten A, Schepers D, Alaerts M, Van Laer L, Loeys BL. Differences in manifestations of Marfan syndrome, Ehlers-Danlos syndrome, and Loeys-Dietz syndrome. Ann Cardiothorac Surg. 2017;6:582\u201394. https:\/\/doi.org\/10.21037\/acs.2017.11.03.","journal-title":"Ann Cardiothorac Surg"},{"key":"3787_CR14","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.jfo.2019.01.005","volume":"42","author":"S Perez-Roustit","year":"2019","unstructured":"Perez-Roustit S, Nguyen DT, Xerri O, Robert MP, De Vergnes N, Mincheva Z, et al. [Ocular manifestations in Ehlers-Danlos Syndromes: Clinical study of 21 patients]. J Fr Ophtalmol. 2019;42:722\u20139. https:\/\/doi.org\/10.1016\/j.jfo.2019.01.005.","journal-title":"J Fr Ophtalmol"},{"key":"3787_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2415-12-47","volume":"12","author":"JK Whitaker","year":"2012","unstructured":"Whitaker JK, Alexander P, Chau DY, Tint NL. Severe conjunctivochalasis in association with classic type Ehlers-Danlos syndrome. BMC Ophthalmol. 2012;12:47. https:\/\/doi.org\/10.1186\/1471-2415-12-47.","journal-title":"BMC Ophthalmol"},{"key":"3787_CR16","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/j.1399-0004.2011.01758.x","volume":"82","author":"M Klaassens","year":"2012","unstructured":"Klaassens M, Reinstein E, Hilhorst-Hofstee Y, Schrander JJ, Malfait F, Staal H, et al. Ehlers-Danlos arthrochalasia type (VIIA-B)-expanding the phenotype: from prenatal life through adulthood. Clin Genet. 2012;82:121\u201330. https:\/\/doi.org\/10.1111\/j.1399-0004.2011.01758.x.","journal-title":"Clin Genet"},{"key":"3787_CR17","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3109\/08820538.2013.839814","volume":"30","author":"PA Ozer","year":"2015","unstructured":"Ozer PA, Yalniz-Akkaya Z. Congenital keratoglobus with multiple cardiac anomalies: a case presentation and literature review. Semin Ophthalmol. 2015;30:305\u201312. https:\/\/doi.org\/10.3109\/08820538.2013.839814.","journal-title":"Semin Ophthalmol"},{"key":"3787_CR18","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.ajo.2012.03.023","volume":"154","author":"M Gharbiya","year":"2012","unstructured":"Gharbiya M, Moramarco A, Castori M, Parisi F, Celletti C, Marenco M, et al. Ocular features in joint hypermobility syndrome\/ehlers-danlos syndrome hypermobility type: a clinical and in vivo confocal microscopy study. Am J Ophthalmol. 2012;154:593\u2013600.e1. https:\/\/doi.org\/10.1016\/j.ajo.2012.03.023.","journal-title":"Am J Ophthalmol"},{"key":"3787_CR19","doi-asserted-by":"publisher","first-page":"8062","DOI":"10.1167\/iovs.13-12837","volume":"54","author":"E Villani","year":"2013","unstructured":"Villani E, Garoli E, Bassotti A, Magnani F, Tresoldi L, Nucci P, et al. The cornea in classic type Ehlers-Danlos syndrome: macro- and microstructural changes. Invest Ophthalmol Vis Sci. 2013;54:8062\u20138. https:\/\/doi.org\/10.1167\/iovs.13-12837.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3787_CR20","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1111\/cge.13052","volume":"92","author":"M Colombi","year":"2017","unstructured":"Colombi M, Dordoni C, Venturini M, Ciaccio C, Morlino S, Chiarelli N, et al. Spectrum of mucocutaneous, ocular and facial features and delineation of novel presentations in 62 classical Ehlers-Danlos syndrome patients. Clin Genet. 2017;92:624\u201331. https:\/\/doi.org\/10.1111\/cge.13052.","journal-title":"Clin Genet"},{"key":"3787_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1155","volume":"8","author":"A Louie","year":"2020","unstructured":"Louie A, Meyerle C, Francomano C, Srikumaran D, Merali F, Doyle JJ, et al. Survey of Ehlers-Danlos Patients\u2019 ophthalmic surgery experiences. Mol Genet Genom Med. 2020;8:e1155. https:\/\/doi.org\/10.1002\/mgg3.1155.","journal-title":"Mol Genet Genom Med"},{"key":"3787_CR22","doi-asserted-by":"publisher","first-page":"996458","DOI":"10.3389\/fmed.2022.996458","volume":"9","author":"S Asanad","year":"2022","unstructured":"Asanad S, Bayomi M, Brown D, Buzzard J, Lai E, Ling C, et al. Ehlers-Danlos syndromes and their manifestations in the visual system. Front Med. 2022;9:996458 https:\/\/doi.org\/10.3389\/fmed.2022.996458.","journal-title":"Front Med"},{"key":"3787_CR23","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1136\/pn-2023-003703","volume":"24","author":"FS van Dijk","year":"2024","unstructured":"van Dijk FS, Ghali N, Chandratheva A. Ehlers-Danlos syndromes: importance of defining the type. Pr Neurol. 2024;24:90\u201397. https:\/\/doi.org\/10.1136\/pn-2023-003703.","journal-title":"Pr Neurol"},{"key":"3787_CR24","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1002\/ajmg.a.33070","volume":"149A","author":"BT Tinkle","year":"2009","unstructured":"Tinkle BT, Bird HA, Grahame R, Lavallee M, Levy HP, Sillence D. The lack of clinical distinction between the hypermobility type of Ehlers-Danlos syndrome and the joint hypermobility syndrome (a.k.a. hypermobility syndrome). Am J Med Genet A. 2009;149A:2368\u201370. https:\/\/doi.org\/10.1002\/ajmg.a.33070.","journal-title":"Am J Med Genet A"},{"key":"3787_CR25","doi-asserted-by":"publisher","first-page":"e031365","DOI":"10.1136\/bmjopen-2019-031365","volume":"9","author":"JC Demmler","year":"2019","unstructured":"Demmler JC, Atkinson MD, Reinhold EJ, Choy E, Lyons RA, Brophy ST. Diagnosed prevalence of Ehlers-Danlos syndrome and hypermobility spectrum disorder in Wales, UK: a national electronic cohort study and case\u2013control comparison. BMJ Open. 2019;9:e031365 https:\/\/doi.org\/10.1136\/bmjopen-2019-031365.","journal-title":"BMJ Open"},{"key":"3787_CR26","doi-asserted-by":"publisher","first-page":"e291","DOI":"10.1097\/MD.0000000000000291","volume":"93","author":"R Inokuchi","year":"2014","unstructured":"Inokuchi R, Kurata H, Endo K, Kitsuta Y, Nakajima S, Hatamochi A, et al. Vascular Ehlers-Danlos Syndrome Without the Characteristic Facial Features. Med (Balt). 2014;93:e291 https:\/\/doi.org\/10.1097\/MD.0000000000000291.","journal-title":"Med (Balt)"},{"key":"3787_CR27","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s00403-019-01894-0","volume":"311","author":"F Cortini","year":"2019","unstructured":"Cortini F, Villa C, Marinelli B, Combi R, Pesatori AC, Bassotti A. Understanding the basis of Ehlers-Danlos syndrome in the era of the next-generation sequencing. Arch Dermatol Res. 2019;311:265\u201375. https:\/\/doi.org\/10.1007\/s00403-019-01894-0.","journal-title":"Arch Dermatol Res"},{"key":"3787_CR28","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/eye.1987.34","volume":"1","author":"AJ Bailey","year":"1987","unstructured":"Bailey AJ. Structure, function and ageing of the collagens of the eye. Eye Lond Engl. 1987;1:175\u201383. https:\/\/doi.org\/10.1038\/eye.1987.34.","journal-title":"Eye Lond Engl"},{"key":"3787_CR29","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.preteyeres.2004.04.002","volume":"23","author":"T Ihanam\u00e4ki","year":"2004","unstructured":"Ihanam\u00e4ki T, Pelliniemi LJ, Vuorio E. Collagens and collagen-related matrix components in the human and mouse eye. Prog Retin Eye Res. 2004;23:403\u201334. https:\/\/doi.org\/10.1016\/j.preteyeres.2004.04.002.","journal-title":"Prog Retin Eye Res"},{"key":"3787_CR30","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1001\/archopht.1966.03850010199009","volume":"76","author":"WR Green","year":"1966","unstructured":"Green WR, Friedman-Kien A, Banfield WG. Angioid streaks in Ehlers-Danlos syndrome. Arch Ophthalmol. 1966;76:197\u2013204. https:\/\/doi.org\/10.1001\/archopht.1966.03850010199009.","journal-title":"Arch Ophthalmol"},{"key":"3787_CR31","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1001\/jamaophthalmol.2018.5995","volume":"137","author":"EL Singman","year":"2019","unstructured":"Singman EL, Doyle JJ. Angioid Streaks Are Not a Common Feature of Ehlers-Danlos Syndrome. JAMA Ophthalmol. 2019;137:239 https:\/\/doi.org\/10.1001\/jamaophthalmol.2018.5995.","journal-title":"JAMA Ophthalmol"},{"key":"3787_CR32","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1001\/jamaophthalmol.2019.2549","volume":"137","author":"OA Mahroo","year":"2019","unstructured":"Mahroo OA, Hykin PG. Confirmation That Angioid Streaks Are Not Common in Ehlers-Danlos Syndrome. JAMA Ophthalmol. 2019;137:1463.","journal-title":"JAMA Ophthalmol"},{"key":"3787_CR33","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.4103\/ijo.IJO_286_22","volume":"71","author":"MI Asif","year":"2023","unstructured":"Asif MI, Kalra N, Sharma N, Jain N, Sharma M, Sinha R. Connective tissue disorders and eye: A review and recent updates. Indian J Ophthalmol. 2023;71:2385\u201398. https:\/\/doi.org\/10.4103\/ijo.IJO_286_22, https:\/\/doi.org\/10.1001\/jamaophthalmol.2019.2549.","journal-title":"Indian J Ophthalmol"},{"key":"3787_CR34","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1167\/iovs.64.6.2","volume":"64","author":"MA Bullimore","year":"2023","unstructured":"Bullimore MA, Lee SS, Schmid KL, Rozema JJ, Leveziel N, Mallen E, et al. IMI\u2014Onset and Progression of Myopia in Young Adults. Invest Ophthalmol Vis Sci. 2023;64:2 https:\/\/doi.org\/10.1167\/iovs.64.6.2.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3787_CR35","doi-asserted-by":"publisher","first-page":"510","DOI":"10.18240\/ijo.2022.03.21","volume":"15","author":"Q Yu","year":"2022","unstructured":"Yu Q, Zhou JB. Scleral remodeling in myopia development. Int J Ophthalmol. 2022;15:510\u20134. https:\/\/doi.org\/10.18240\/ijo.2022.03.21.","journal-title":"Int J Ophthalmol"},{"key":"3787_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-96775-w","volume":"11","author":"S Kling","year":"2021","unstructured":"Kling S, Torres-Netto EA, Abdshahzadeh H, Espana EM, Hafezi F. Collagen V insufficiency in a mouse model for Ehlers Danlos-syndrome affects viscoelastic biomechanical properties explaining thin and brittle corneas. Sci Rep. 2021;11:17362. https:\/\/doi.org\/10.1038\/s41598-021-96775-w.","journal-title":"Sci Rep"},{"key":"3787_CR37","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1292\/jvms.18-0019","volume":"80","author":"T Hirose","year":"2018","unstructured":"Hirose T, Suzuki I, Takahashi N, Fukada T, Tangkawattana P, Takehana K. Morphometric analysis of cornea in the Slc39a13\/Zip13-knockout mice. J Vet Med Sci. 2018;80:814\u20138. https:\/\/doi.org\/10.1292\/jvms.18-0019.","journal-title":"J Vet Med Sci"},{"key":"3787_CR38","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1167\/iovs.05-0771","volume":"47","author":"F Segev","year":"2006","unstructured":"Segev F, H\u00e9on E, Cole WG, Wenstrup RJ, Young F, Slomovic AR, et al. Structural abnormalities of the cornea and lid resulting from collagen V mutations. Invest Ophthalmol Vis Sci. 2006;47:565\u201373. https:\/\/doi.org\/10.1167\/iovs.05-0771.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3787_CR39","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1080\/13816810.2017.1313993","volume":"38","author":"J Swierkowska","year":"2017","unstructured":"Swierkowska J, Gajecka M. Genetic factors influencing the reduction of central corneal thickness in disorders affecting the eye. Ophthalmic Genet. 2017;38:501\u201310. https:\/\/doi.org\/10.1080\/13816810.2017.1313993.","journal-title":"Ophthalmic Genet"},{"key":"3787_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-8-68","volume":"8","author":"EM Burkitt Wright","year":"2013","unstructured":"Burkitt Wright EM, Porter LF, Spencer HL, Clayton-Smith J, Au L, Munier FL, et al. Brittle cornea syndrome: recognition, molecular diagnosis and management. Orphanet J Rare Dis. 2013;8:68. https:\/\/doi.org\/10.1186\/1750-1172-8-68.","journal-title":"Orphanet J Rare Dis"},{"key":"3787_CR41","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.survophthal.2021.04.006","volume":"67","author":"RO Baratta","year":"2022","unstructured":"Baratta RO, Schlumpf E, Buono BJD, DeLorey S, Calkins DJ. Corneal collagen as a potential therapeutic target in dry eye disease. Surv Ophthalmol. 2022;67:60\u201367. https:\/\/doi.org\/10.1016\/j.survophthal.2021.04.006.","journal-title":"Surv Ophthalmol"},{"key":"3787_CR42","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/ajmg.c.31549","volume":"175","author":"FC Henderson Sr","year":"2017","unstructured":"Henderson FC Sr, Austin C, Benzel E, Bolognese P, Ellenbogen R, Francomano CA, et al. Neurological and spinal manifestations of the Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet. 2017;175:195\u2013211. https:\/\/doi.org\/10.1002\/ajmg.c.31549.","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"3787_CR43","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.nec.2022.09.001","volume":"34","author":"M Ellington","year":"2023","unstructured":"Ellington M, Francomano CA. Chiari I Malformations and the Heritable Disorders of Connective Tissue. Neurosurg Clin N Am. 2023;34:61\u201365. https:\/\/doi.org\/10.1016\/j.nec.2022.09.001.","journal-title":"Neurosurg Clin N Am"},{"key":"3787_CR44","doi-asserted-by":"publisher","first-page":"E3","DOI":"10.3171\/foc.2000.8.3.3","volume":"8","author":"G Pinna","year":"2000","unstructured":"Pinna G, Alessandrini F, Alfieri A, Rossi M, Bricolo A. Cerebrospinal fluid flow dynamics study in Chiari I malformation: implications for syrinx formation. Neurosurg Focus. 2000;8:E3 https:\/\/doi.org\/10.3171\/foc.2000.8.3.3.","journal-title":"Neurosurg Focus"},{"key":"3787_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-62374-8","volume":"14","author":"S Vandenbulcke","year":"2024","unstructured":"Vandenbulcke S, Condron P, Safaei S, Holdsworth S, Degroote J, Segers P. A computational fluid dynamics study to assess the impact of coughing on cerebrospinal fluid dynamics in Chiari type 1 malformation. Sci Rep. 2024;14:12717. https:\/\/doi.org\/10.1038\/s41598-024-62374-8.","journal-title":"Sci Rep"},{"key":"3787_CR46","doi-asserted-by":"publisher","first-page":"bcr2013010990","DOI":"10.1136\/bcr-2013-010990","volume":"2014","author":"I Linfante","year":"2014","unstructured":"Linfante I, Lin E, Knott E, Katzen B, Dabus G. Endovascular repair of direct carotid-cavernous fistula in Ehlers-Danlos type IV. BMJ Case Rep. 2014;2014:bcr2013010990 https:\/\/doi.org\/10.1136\/bcr-2013-010990.","journal-title":"BMJ Case Rep"},{"key":"3787_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-018-0842-2","volume":"13","author":"S Adham","year":"2018","unstructured":"Adham S, Trystram D, Albuisson J, Domigo V, Legrand A, Jeunemaitre X, et al. Pathophysiology of carotid-cavernous fistulas in vascular Ehlers-Danlos syndrome: a retrospective cohort and comprehensive review. Orphanet J Rare Dis. 2018;13:100. https:\/\/doi.org\/10.1186\/s13023-018-0842-2.","journal-title":"Orphanet J Rare Dis"},{"key":"3787_CR48","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1001\/archopht.1997.01100150418018","volume":"115","author":"JS Pollack","year":"1997","unstructured":"Pollack JS, Custer PL, Hart WM, Smith ME, Fitzpatrick MM. Ocular complications in Ehlers-Danlos syndrome type IV. Arch Ophthalmol Chic Ill 1960. 1997;115:416\u20139. https:\/\/doi.org\/10.1001\/archopht.1997.01100150418018.","journal-title":"Arch Ophthalmol Chic Ill 1960"},{"key":"3787_CR49","doi-asserted-by":"publisher","first-page":"57","DOI":"10.4103\/0974-9233.53862","volume":"16","author":"IA Chaudhry","year":"2009","unstructured":"Chaudhry IA, Elkhamry SM, Al-Rashed W, Bosley TM. Carotid cavernous fistula: ophthalmological implications. Middle East Afr J Ophthalmol. 2009;16:57\u201363. https:\/\/doi.org\/10.4103\/0974-9233.53862.","journal-title":"Middle East Afr J Ophthalmol"},{"key":"3787_CR50","doi-asserted-by":"publisher","first-page":"e19236","DOI":"10.1097\/MD.0000000000019236","volume":"99","author":"L Yin","year":"2020","unstructured":"Yin L, Zhang D, Ren Q, Su X, Sun Z. Prevalence and risk factors of diabetic retinopathy in diabetic patients: A community based cross-sectional study. Med (Balt). 2020;99:e19236 https:\/\/doi.org\/10.1097\/MD.0000000000019236.","journal-title":"Med (Balt)"},{"key":"3787_CR51","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.mcna.2021.01.003","volume":"105","author":"CJ Thomas","year":"2021","unstructured":"Thomas CJ, Mirza RG, Gill MK. Age-related macular degeneration. Med Clin North Am. 2021;105:473\u201391. https:\/\/doi.org\/10.1016\/j.mcna.2021.01.003.","journal-title":"Med Clin North Am"},{"key":"3787_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-022-00342-0","volume":"8","author":"CY Cheung","year":"2022","unstructured":"Cheung CY, Biousse V, Keane PA, Schiffrin EL, Wong TY. Hypertensive eye disease. Nat Rev Dis Prim. 2022;8:1\u201318. https:\/\/doi.org\/10.1038\/s41572-022-00342-0.","journal-title":"Nat Rev Dis Prim"},{"key":"3787_CR53","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/dmcn.15468","volume":"65","author":"O Dammann","year":"2023","unstructured":"Dammann O, Hartnett ME, Stahl A. Retinopathy of prematurity. Dev Med Child Neurol. 2023;65:625\u201331. https:\/\/doi.org\/10.1111\/dmcn.15468.","journal-title":"Dev Med Child Neurol"},{"key":"3787_CR54","doi-asserted-by":"publisher","first-page":"3459","DOI":"10.1007\/s43032-022-00992-1","volume":"29","author":"LA Underhill","year":"2022","unstructured":"Underhill LA, Barbarita C, Collis S, Tucker R, Lechner BE. Association of maternal versus fetal Ehlers-Danlos syndrome status with poor pregnancy outcomes. Reprod Sci. 2022;29:3459\u201364. https:\/\/doi.org\/10.1007\/s43032-022-00992-1.","journal-title":"Reprod Sci"},{"key":"3787_CR55","doi-asserted-by":"publisher","first-page":"101634","DOI":"10.1016\/j.cpcardiol.2023.101634","volume":"48","author":"N Alrifai","year":"2023","unstructured":"Alrifai N, Alhuneafat L, Jabri A, Khalid MU, Tieliwaerdi X, Sukhon F, et al. Pregnancy and fetal outcomes in patients with ehlers-danlos syndrome: a nationally representative analysis. Curr Probl Cardiol. 2023;48:101634 https:\/\/doi.org\/10.1016\/j.cpcardiol.2023.101634.","journal-title":"Curr Probl Cardiol"},{"key":"3787_CR56","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1001\/jamaophthalmol.2024.0046","volume":"142","author":"J Markle","year":"2024","unstructured":"Markle J, Shaia JK, Araich H, Sharma N, Talcott KE, Singh RP. Longitudinal trends and disparities in diabetic retinopathy within an aggregate health care network. JAMA Ophthalmol. 2024;142:599\u2013606. https:\/\/doi.org\/10.1001\/jamaophthalmol.2024.0046.","journal-title":"JAMA Ophthalmol"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-03787-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-03787-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-03787-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T09:01:59Z","timestamp":1751274119000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-03787-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,10]]},"references-count":56,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["3787"],"URL":"https:\/\/doi.org\/10.1038\/s41433-025-03787-1","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,10]]},"assertion":[{"value":"6 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"DK reports personal fees from Dynavax Technologies Corporation. RS reports personal fees from Apellis, Iveric Bio, Eyepoint, Regenxbio, Genentech, Bausch and Lomb, Zeiss, Alcon, and Regeneron, and research grants from Janssen. KT reports personal fees from Alimera, Abbvie, Apellis, Astellas, Eyepoint, Genentech, Outlook, Regeneron, and Zeiss, and research fees from Regeneron and Zeiss.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}